A pilot open-label trial of minocycline in patients with autism and regressive features.

J Neurodev Disord · 2013 · PMC3663771 · PMID 23566357

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

a decreasing trendP = 0.059so close (0.05 < p ≤ 0.1)

Concentrations of MMPs in this study were unaffected after treatment with minocycline and only MMP-7 disclosed a decreasing trend ( P = 0.059) while MMP-9, a putative target of minocycline effect [ 43 ], was unchanged after treatment.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.